最新报道:Injective (INJ) is testing a critical trendline support dating back to April, with a potential breakdown risking a drop to $12 or even $10.3 in the coming weeks. Analysts note bearish signals across multiple timeframes, including repeated rejections at the $15.48 resistance and weakening technical indicators like the CMF and MACD. The $12 demand zone remains a key level to watch amid ongoing selling pressure.